24 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
their technology, we could have to defend an expensive and time consuming lawsuit, pay a large sum if we are found to be infringing, or be prohibited from
8-K
EX-10.1
CTCX
Carmell Corp - Ordinary Shares
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
, infringement, misappropriation or a claim or lawsuit, the Company does not have any liabilities or obligations that would be required to be disclosed
8-K
EX-10.1
k1tdwni
5 Jan 24
Departure of Directors or Certain Officers
4:39pm
8-K
EX-10.1
ydleih
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
424B3
7w03yw 97c4
23 Jun 23
Prospectus supplement
4:47pm
10-K
zqa9j4rtt65jas3
15 Apr 22
Annual report
5:11pm
424B4
4ub4zzqmp5ja2r14eg
27 Jul 21
Prospectus supplement with pricing info
10:42am